Search - tctmd.com

Displaying 1 - 20 of 82

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Features

Year in Review: Women’s Heart Health in the Spotlight

Caitlin E. Cox

December 23, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Daily News

Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD

Caitlin E. Cox

July 23, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

Having Twins Ups the Risk of CVD Over the Next Year

Caitlin E. Cox

February 06, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

L.A. McKeown

January 10, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2024

Shelley Wood

October 01, 2024

News Conference News SCCT 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

Todd Neale

July 22, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Daily News

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

Michael O'Riordan

September 14, 2023

Advertisement

TCTMD’s Top 10 Most Popular Stories for January 2026

Heart Disease Remains Number One Killer of Americans

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Year in Review: Women’s Heart Health in the Spotlight

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Frail Patients Stand to Gain Most From Cardiac Rehab

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

July 2025 Dispatch for the CV Team

Physical Activity Ebbs, Flows Over a Lifetime but Rarely Rebounds After CVD

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Having Twins Ups the Risk of CVD Over the Next Year

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

TCTMD’s Top 10 Most Popular Stories for December 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

TCTMD’s Top 10 Most Popular Stories for September 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content